SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 10, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago
Insider cluster: 3 insiders, $1.2M total
Actionable Insight • Neutral

Monitor upcoming quarterly earnings for any fundamental changes. The insider selling is too small to be actionable on its own.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$545.40
T+0 close · Jun 10, 2026 · via day close
Latest settled
−10.64%
T+60 · $487.35
Vs SPY
−15.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $545.40entry
  2. T+1 · 5mo ago +0.10%α −0.44% · $545.96
  3. T+5 · 5mo ago +1.11%α +0.68% · $551.47
  4. T+20 · 4mo ago +1.30%α −0.59% · $552.48
  5. T+60 · 2mo ago −10.64%α −15.04% · $487.35
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A small insider selling cluster at United Therapeutics (UTHR) saw the CEO, CFO, and EVP/GCO sell a combined ~$1.23M in open-market shares over a week, but this represents less than 0.01% of the company's $23.5B market cap. The sales follow option exercises and appear routine for tax withholding or liquidity. No material signal for traders.

Key Financial Metrics

Direction
selling
Total Value
$1.2M
Insiders
3

Key Facts

  • Three insiders sold ~$1.23M in open-market shares, 0.005% of market cap.
  • CEO Martine Rothblatt sold 491 shares ($267K), CFO James Edgemond sold 1,565 shares ($853K), EVP Paul Mahon sold 200 shares ($108K).
  • All sales occurred after exercising derivative securities, indicating routine tax-related or liquidity-driven transactions.
  • Open-market sales were a tiny fraction of the shares acquired via option exercises.
  • No significant insider buying or unusual pattern detected.

Financial Impact

Total insider sales of $1.23M, negligible relative to $23.5B market cap.

Risk Factors

  • Insider sales could precede negative news, but the scale here is minimal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1781124226769

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026